PROPHYLAXIS WITH UROKINASE IN PEDIATRIC ONCOLOGY PATIENTS WITH CENTRAL VENOUS CATHETERS

This study evaluated the effects of urokinase in the prevention of central venous catheter (CVC)-related complications in children with malignancy. Fifteen patients with 16 CVCs (study group A) received an intraluminal application of urokinase (10,000 IU in each catheter lumen for 4 h) once a week....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric hematology and oncology 2002, Vol.19 (3), p.173-179
Hauptverfasser:	Kalmanti, Maria, Germanakis, John, Stiakaki, Eftichia, Sfyridaki, Cathrin, Christidou, Athanasia, Tsetis, Dimitris, Vardas, Panagiotis, Charisis, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteremia - drug therapy Bacteremia - etiology Bacteremia - prevention & control Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Catheterization, Central Venous - adverse effects Central Venous Catheter Child Child, Preschool Childhood Malignancy Humans Infant Male Medical sciences Neoplasms - complications Neoplasms - drug therapy Neoplasms - therapy Pharmacology. Drug treatments Plasminogen Activators - administration & dosage Plasminogen Activators - therapeutic use Prospective Studies Thrombosis - drug therapy Thrombosis - etiology Thrombosis - prevention & control Urokinase Urokinase-Type Plasminogen Activator - administration & dosage Urokinase-Type Plasminogen Activator - therapeutic use Urokinase-Type Plasminogen Activator - toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!